SOCMA in the News Archive
The Safety of Chemicals
Re “Think Those Chemicals Have Been Tested?” (news analysis, Sunday Review, April 14) and “A Toothless Law on Toxic Chemicals” (editorial, April 19):
WASHINGTON, May 31, 2012 /PRNewswire-USNewswire/ -- Just days after the Senate overwhelming approved legislation to better protect the nation's drug supply, the House of Representatives last night followed suit, passing the Food and Drug Administration Reform Act of 2012 (H.R. 5651) in a 387-5 vote.
Some might call it chemistry, the way Larry Sloan found his way to the top spot of an industry association.
Americans might expect their prescription drugs to be “Made in the U.S.A.,” but just like clothing or electronics, their medicine is increasingly produced in developing nations. In fact, according to a U.S. Government Accountability Office (GAO) report, at least 80 percent of the ingredients in U.S. drugs now originate overseas. This could be real cause for concern.
Ten years after the terrorist attacks on Sept. 11, 2001, public health and safety watchdogs are increasingly concerned that the country's program for securing chemical facilities from terrorists and thefts contains significant loopholes and leaves millions of Americans at risk.
Published August 16, 2011 | Reuters - U.S. regulators and generic drugmakers have reached a compromise agreement for a user-fee program that would require the companies to pay some $299 million in the first year to accelerate drug approvals.
Aug. 2 is Looming - As the debate over the U.S credit crisis is coming down to the wire, American businesses are also warily watching the developments. A U.S. default would bring serious economic ramifications worldwide, and American businesses would be at the epicenter. Brandi Schuster asked Society of Chemical Manufacturers and Associates (SOCMA) President Lawrence D. Sloan what a default would mean for American chemical companies.
As anyone who has ever tried to shout at a player during a soccer game surely knows, it's almost impossible to for a relatively small voice to be heard in the middle of a crowd - no matter how good the tactical advice coming from the stands might be. Looking at the chemical industry, between all of the large multinationals are a considerable number of small- and mid-sized companies, often times owned by families or private equity firms. Making sure their interests are fairly represented is no easy task, especially in the U.S., where a whole host of regulatory issues are now coming to the forefront.
BALTIMORE, Maryland (ICIS)--Social and political unrest in the Middle East and the still-unfolding natural and nuclear power disasters in Japan will have an impact on US chemicals manufacturers, an industry leader said on Wednesday.... Lawrence Sloan, president of the Society of Chemical Manufacturers and Affiliates (SOCMA), said that even though little or no Libyan oil serves as feedstock for US manufacturers, ultimately there would be a spill-over effect for domestic producers.
New York Times published a piece on the potential for a jurisdictional fight over chemical security legislation in the House, which quotes SOCMA’s Bill Allmond, SOCMA Vice President of Government Relations, on our support for a long-term reauthorization of CFATS.next ›››
What Members Are Saying…
“Several of our facilities are involved in processes related to food and feed applications and must be certified under various initiatives. We have found that in many cases the systems we have established under the ChemSystems program serve as great building platforms for meeting the requirements for these other certifications, and as a result the approval process has been greatly simplified.”